ICER Dumps on Wegovy Cost-Effectiveness; Kerendia Label Update; Synthetic Embryos?

(MedPage Today) -- The Institute for Clinical and Economic Review (ICER) said that while subcutaneous semaglutide (Wegovy) "is more effective, less burdensome, and more cost effective than liraglutide [Victoza]," it "does not meet typical cost...